Detalles de la búsqueda
1.
Evaluating the impact of calibration of patient-reported outcomes measures on results from randomized clinical trials: a simulation study based on Rasch measurement theory.
BMC Med Res Methodol
; 22(1): 224, 2022 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35962310
2.
Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies.
Mult Scler J Exp Transl Clin
; 9(3): 20552173231201422, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37780483
3.
Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosis.
J Patient Rep Outcomes
; 7(1): 61, 2023 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402086
4.
A toolbox of different approaches to analyze and present PRO-CTCAE data in oncology studies.
J Natl Cancer Inst
; 115(5): 586-596, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715639
5.
Is the St. George's Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials.
Int J Chron Obstruct Pulmon Dis
; 15: 2103-2113, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32982203
Resultados
1 -
5
de 5
1
Próxima >
>>